AFNAS
UTHR icon

American Financial Network Advisory Services’s United Therapeutics UTHR Stock Holding History

American Financial Network Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23
Closed -$3K – 564
2017
Q4 		$3K Hold
23
– – ﹤0.01% 620
2017
Q3 		$3K Buy
+23
New +$2.94K ﹤0.01% 670

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

American Financial Network Advisory Services's UTHR Position: Q1 2018 in Review

American Financial Network Advisory Services sold out of United Therapeutics (UTHR) in Q1 2018, closing a stake of 23 shares — an estimated $3K sold.

American Financial Network Advisory Services first reported a position in UTHR in Q3 2017 and held it in 2 quarters. The position peaked at $3K in Q4 2017. 374 funds tracked by Wall St. Rank hold UTHR as of Q1 2018.

  • American Financial Network Advisory Services reported no remaining United Therapeutics position as of Q1 2018 after selling out during the quarter.
  • American Financial Network Advisory Services sold 23 United Therapeutics shares in Q1 2018, an estimated $3K.
  • American Financial Network Advisory Services first reported a position in United Therapeutics in Q3 2017 and held it in 2 quarters.
  • American Financial Network Advisory Services's United Therapeutics position peaked at $3K in Q4 2017.
  • 374 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2018.

Based on American Financial Network Advisory Services's 13F filing for Q1 2018, filed 15 May 2018.